Pre-surgical oncolytic virotherapy improves breast cancer outcomes
Sign Up to like & getrecommendations! Published in 2019 at "Oncoimmunology"
DOI: 10.1080/2162402x.2019.1655363
Abstract: ABSTRACT Oncolytic viruses (OVs) are a novel class of cancer biotherapeutics with the ability to kill cancers and trigger anti-tumor immunity. Using murine models of cancer in pre-clinical proof-of-concept studies, we found that neoadjuvant OV… read more here.
Keywords: pre surgical; surgical oncolytic; cancer; improves breast ... See more keywords